ProBio announced today that it launched new cGMP adeno-associated virus (AAV) manufacturing services in Hopewell, New Jersey. The company added the services at its 128,000-square-foot, state-of-the-art facility to meet growing industry demand for high-quality viral vector production. It said the additional capacity reflects its ongoing commitment to supporting the advancement of life-changing gene therapies. ProBio…